Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company that originally filed its offer documents for NSE SME listing is now settling for BSE SME listing and raises concern over the IPO approval process. Boosted profits for the current fiscal first nine months’ performance raises eyebrows and suspension on window dressing for such fancy valuation and lure investors. Despite super earnings for 9M-FY22, its IPO pricing is at a higher P/E of 38. There is no harm in skipping this pricy bet. Read detail review...
Global Longlife Hospital IPO Reviews, analysis and views by popular members. Read Global Longlife Hospital & Research Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
Useful Articles
RHP